-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
ATAI Life Sciences N.V. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2024.
- ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $19K, a 89.7% decline year-over-year.
- ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $681K, a 89.5% decline year-over-year.
- ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2023 was $1.02M, a 83.7% decline from 2022.
- ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2022 was $6.23M, a 56.2% increase from 2021.
- ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2021 was $3.99M, a 1208% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)